Effects and mechanism analysis of vascular endothelial growth factor and salvianolic acid B on 125I-low density lipoprotein permeability of the rabbit aortary endothelial cells
- PMID: 25005771
- DOI: 10.1007/s12013-014-0089-z
Effects and mechanism analysis of vascular endothelial growth factor and salvianolic acid B on 125I-low density lipoprotein permeability of the rabbit aortary endothelial cells
Abstract
Atherosclerosis is the common pathological basis of cardiovascular and cerebrovascular disease. This study aimed to investigate the effects of vascular endothelial growth factor (VEGF) and salvianolic acid B (SalB) on the permeability of the rabbit aortary endothelial cells (RAECs) and to figure out the possible underlying molecular mechanisms. The extravasation of (125)I-low density lipoprotein ((125)I-LDL) through the RAECs was significantly increased by VEGF and decreased by SalB. Meanwhile, the tight junction-associated proteins occludin and claudin-5 were found downregulated by VEGF and the caveolae structure proteins caveolin-1 and caveolin-2 upregulated, which were abolished by the infusion of SalB. In addition, a marked increase in levels of cGMP and protein kinase G-1 (PKG-1) as well as activation of nuclear factor-κB (NF-κB) p65 were found after VEGF infusion, which were attenuated by SalB. This study demonstrates that VEGF and SalB can alter the LDL permeability of the RAECs by a paracellular pathway (downregulation of occludin and claudin-5) and a transcellular pathway (upregulation of caveolin-1 and caveolin-2), in which the cGMP/PKG/NF-κB signal pathway is possibly involved. The experimental results provide a new method and basic knowledge of prevention and treatment for cardiovascular and cerebrovascular disease.
Similar articles
-
Permeability of the blood-tumor barrier is enhanced by combining vascular endothelial growth factor with papaverine.J Neurosci Res. 2014 Jun;92(6):703-13. doi: 10.1002/jnr.23348. Epub 2014 Feb 12. J Neurosci Res. 2014. PMID: 24523141
-
VEGF induced hyperpermeability in bovine aortic endothelial cell and inhibitory effect of salvianolic acid B.Acta Pharmacol Sin. 2001 Feb;22(2):117-20. Acta Pharmacol Sin. 2001. PMID: 12545975
-
Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.Toxicol Appl Pharmacol. 2013 Dec 15;273(3):651-8. doi: 10.1016/j.taap.2013.10.012. Epub 2013 Oct 19. Toxicol Appl Pharmacol. 2013. PMID: 24145059
-
Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells.J Cell Biochem. 2005 Sep 1;96(1):109-16. doi: 10.1002/jcb.20567. J Cell Biochem. 2005. PMID: 16052513
-
Postprandial lipoproteins and the molecular regulation of vascular homeostasis.Prog Lipid Res. 2013 Oct;52(4):446-64. doi: 10.1016/j.plipres.2013.06.001. Epub 2013 Jun 15. Prog Lipid Res. 2013. PMID: 23774609 Review.
Cited by
-
The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms.Oxid Med Cell Longev. 2020 Sep 25;2020:5472096. doi: 10.1155/2020/5472096. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33062143 Free PMC article. Review.
-
Inhibition of Vascular Endothelial Cadherin Cleavage Prevents Elastic Fiber Alterations and Atherosclerosis Induced by Intermittent Hypoxia in the Mouse Aorta.Int J Mol Sci. 2022 Jun 24;23(13):7012. doi: 10.3390/ijms23137012. Int J Mol Sci. 2022. PMID: 35806017 Free PMC article.
-
Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage.Front Pharmacol. 2020 Nov 11;11:572373. doi: 10.3389/fphar.2020.572373. eCollection 2020. Front Pharmacol. 2020. PMID: 33343348 Free PMC article. Review.
-
Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases.Front Pharmacol. 2025 Jun 27;16:1606146. doi: 10.3389/fphar.2025.1606146. eCollection 2025. Front Pharmacol. 2025. PMID: 40657643 Free PMC article. Review.
-
Significant Modules and Biological Processes between Active Components of Salvia miltiorrhiza Depside Salt and Aspirin.Evid Based Complement Alternat Med. 2016;2016:3439521. doi: 10.1155/2016/3439521. Epub 2016 Mar 16. Evid Based Complement Alternat Med. 2016. PMID: 27069488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources